139 related articles for article (PubMed ID: 3965688)
1. Antidiuretic hormone antagonists and aquaresis in dogs: different vasopressin sensitivity and antagonist potency in renal cortex and papilla.
Stassen FL; Heckman GD; Huffman WF; Kinter LB
J Pharmacol Exp Ther; 1985 Jan; 232(1):100-5. PubMed ID: 3965688
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action and structural requirements of vasopressin analog inhibition of transepithelial water flux in toad urinary bladder.
Mann WA; Stassen F; Huffman W; Kinter LB
J Pharmacol Exp Ther; 1986 Aug; 238(2):401-6. PubMed ID: 3090234
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of novel antidiuretic antagonists: analysis of the effects on vasopressin binding and adenylate cyclase activation in animal and human kidney.
Stassen FL; Erickson RW; Huffman WF; Stefankiewicz J; Sulat L; Wiebelhaus VD
J Pharmacol Exp Ther; 1982 Oct; 223(1):50-4. PubMed ID: 7120127
[TBL] [Abstract][Full Text] [Related]
4. Desensitization of renal vasopressin-stimulated adenylate cyclase by a vasopressor and antidiuretic antagonist, [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-ethyl)-D-tyrosine, 4-valine]arginine vasopressin.
Chang P; Kimura K
Biochem Biophys Res Commun; 1987 Apr; 144(2):770-8. PubMed ID: 3579941
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin antagonism in the squirrel monkey (Saimiri sciureus).
Kinter LB; Churchill S; Stassen FL; Moore M; Huffman W
J Pharmacol Exp Ther; 1987 Jun; 241(3):797-803. PubMed ID: 3598903
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of renal adenylate cyclase-coupled vasopressin receptors after chronic administration of vasopressin antagonists to rats.
Caltabiano S; Kinter LB
J Pharmacol Exp Ther; 1991 Sep; 258(3):1046-54. PubMed ID: 1832462
[TBL] [Abstract][Full Text] [Related]
7. Effects of vasopressin antagonist on vasopressin binding, adenylate cyclase activation, and water flux.
Kim JK; Dillingham MA; Summer SN; Ishikawa S; Anderson RJ; Schrier RW
J Clin Invest; 1985 Oct; 76(4):1530-5. PubMed ID: 2997281
[TBL] [Abstract][Full Text] [Related]
8. Responses to vasopressin and desmopressin of human cerebral arteries.
Martinez MC; Aldasoro M; Vila JM; Medina P; Lluch S
J Pharmacol Exp Ther; 1994 Aug; 270(2):622-7. PubMed ID: 8071854
[TBL] [Abstract][Full Text] [Related]
9. Modulation of parathyroid hormone-sensitive adenylate cyclase and arginine vasopressin-sensitive adenylate cyclase by calcium and GTP.
Chen TC; Puschett JB
Arch Biochem Biophys; 1981 Dec; 212(2):660-7. PubMed ID: 6798940
[No Abstract] [Full Text] [Related]
10. An investigation into the influence of vasopressin on perfusion of the cortex and papilla of the rat kidney.
Huang CL; Davis G; Johns EJ
Exp Physiol; 1991 May; 76(3):399-408. PubMed ID: 1831621
[TBL] [Abstract][Full Text] [Related]
11. SK&F 105494: a potent antidiuretic hormone antagonist devoid of partial agonist activity in dogs.
Caldwell N; Brickson B; Kinter LB; Brooks DP; Huffman WF; Stassen FL; Albrightson-Winslow C
J Pharmacol Exp Ther; 1988 Dec; 247(3):897-901. PubMed ID: 3204522
[TBL] [Abstract][Full Text] [Related]
12. Vascular vasopressin receptors mediate inhibition of beta adrenergic receptor-induced cyclic AMP accumulation.
Nambi P; Whitman M; Stassen FL; Crooke ST
J Pharmacol Exp Ther; 1986 Apr; 237(1):143-6. PubMed ID: 3007735
[TBL] [Abstract][Full Text] [Related]
13. Evidence for two different stimulatory adenylate cyclase coupling mechanisms in rat renal papilla.
Woodcock EA
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(4):301-16. PubMed ID: 2947938
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of parathyroid hormone-responsive renal cortical adenylate cyclase activity by a cytosol protein activator from rat reticulocytes.
Shane E; Avioli RC; Greene VS; Yeh M; Owens JM; Bell NH; Bilezikian JP
J Bone Miner Res; 1986 Feb; 1(1):41-50. PubMed ID: 3503532
[TBL] [Abstract][Full Text] [Related]
15. Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4.
Manning M; Olma A; Klis WA; Seto J; Sawyer WH
J Med Chem; 1983 Nov; 26(11):1607-13. PubMed ID: 6631916
[TBL] [Abstract][Full Text] [Related]
16. Cellular action of antidiuretic hormone in mice with inherited vasopressin-resistant urinary concentrating defects.
Dousa TP; Valtin H
J Clin Invest; 1974 Sep; 54(3):753-62. PubMed ID: 4368480
[TBL] [Abstract][Full Text] [Related]
17. Effect of the vasopressin antagonist d/CH2/5Tyr/Et/VAVP on the antidiuretic action of exogenous and endogenous vasopressin.
László FA; Csáti S; Baláspiri L
Acta Endocrinol (Copenh); 1984 May; 106(1):52-5. PubMed ID: 6730854
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin-dependent adenylate cyclase activities in the rat kidney medulla: evidence for two separate sites of action.
Imbert-Teboul M; Chabardès D; Montégut M; Clique A; Morel F
Endocrinology; 1978 Apr; 102(4):1254-61. PubMed ID: 744023
[TBL] [Abstract][Full Text] [Related]
19. Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitors.
Butlen D; Guillon G; Rajerison RM; Jard S; Sawyer WH; Manning M
Mol Pharmacol; 1978 Nov; 14(6):1006-17. PubMed ID: 732809
[No Abstract] [Full Text] [Related]
20. The effect of arginine vasopressin and its analogs on the synthesis of prostaglandin E2 by rat renal medullary interstitial cells in culture.
Beck TR; Hassid A; Dunn MJ
J Pharmacol Exp Ther; 1980 Oct; 215(1):15-9. PubMed ID: 7452479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
